BIOCRYST PHARMACEUTICALS INC revenue breakdown overview

BIOCRYST PHARMACEUTICALS INC revenue for the last year amounted to 300.26 M EUR, the most of which — 300.26 M EUR — came from its highest performing source at the moment, Oral Small Molecule and Protein Therapeutics, the year earlier bringing 253.05 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOCRYST PHARMACEUTICALS INC 261.26 M EUR.